IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

被引:365
作者
Mumm, John B. [1 ]
Emmerich, Jan [1 ]
Zhang, Xueqing [1 ]
Chan, Ivan [1 ]
Wu, Lingling [1 ]
Mauze, Smita [1 ]
Blaisdell, Steven [2 ]
Basham, Beth [1 ]
Dai, Jie [1 ]
Grein, Jeff [1 ]
Sheppard, Catherine [1 ]
Hong, Kyu [1 ]
Cutler, Collette [2 ]
Turner, Scott [1 ]
LaFace, Drake [1 ]
Kleinschek, Melanie [1 ]
Judo, Michael [1 ]
Ayanoglu, Gulesi [1 ]
Langowski, John [1 ]
Gu, Danling [1 ]
Paporello, Brittany [2 ]
Murphy, Erin [1 ]
Sriram, Venkataraman [1 ]
Naravula, Saraswathi [1 ]
Desai, Bela [1 ]
Medicherla, Satya [1 ]
Seghezzi, Wolfgang [1 ]
McClanahan, Terrill [1 ]
Cannon-Carlson, Susan [2 ]
Beebe, Amy M. [1 ]
Oft, Martin [1 ]
机构
[1] Merck Res Labs, Palo Alto, CA 94301 USA
[2] Merck Res Labs, Biotechnol Dev, Union, NJ 07083 USA
关键词
EFFECTOR T-CELLS; INTERLEUKIN-10; CANCER; MELANOMA; INDUCTION; PROMOTES; BREAST; HOST;
D O I
10.1016/j.ccr.2011.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor immune surveillance and cancer immunotherapies are thought to depend on the intratumoral infiltration of activated CD8(+) T cells. Intratumoral CD8(+) T cells are rare and lack activity. IL-10 is thought to contribute to the underlying immune suppressive microenvironment. Defying those expectations we demonstrate that IL-10 induces several essential mechanisms for effective antitumor immune surveillance: infiltration and activation of intratumoral tumor-specific cytotoxic CD8(+) T cells, expression of the Th1 cytokine interferon-gamma (IFN gamma) and granzymes in CD8(+) T cells, and intratumoral antigen presentation molecules. Consequently, tumor immune surveillance is weakened in mice deficient for IL-10 whereas transgenic overexpression of IL-10 protects mice from carcinogenesis. Treatment with pegylated IL-10 restores tumor-specific intratumoral CD8(+) T cell function and controls tumor growth.
引用
收藏
页码:781 / 796
页数:16
相关论文
共 43 条
[1]   Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[2]   Cancer - An inflammatory link [J].
Balkwill, F ;
Coussens, LM .
NATURE, 2004, 431 (7007) :405-406
[3]  
Berman RM, 1996, J IMMUNOL, V157, P231
[4]   Interleukin-10 determines viral clearance or persistence in vivo [J].
Brooks, David G. ;
Trifilo, Matthew J. ;
Edelmann, Kurt H. ;
Teyton, Luc ;
McGavern, Dorian B. ;
Oldstone, Michael B. A. .
NATURE MEDICINE, 2006, 12 (11) :1301-1309
[5]  
CHEN WF, 1991, J IMMUNOL, V147, P528
[6]   Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis [J].
Cua, DJ ;
Groux, H ;
Hinton, DR ;
Stohlman, SA ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :1005-1010
[7]   Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M [J].
Deng, Jane C. ;
Cheng, Genhong ;
Newstead, Michael W. ;
Zeng, Xianying ;
Kobayashi, Koichi ;
Flavell, Richard A. ;
Standiford, Theodore J. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2532-2542
[8]  
Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
[9]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[10]   Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ [J].
Fujii, S ;
Shimizu, K ;
Shimizu, T ;
Lotze, MT .
BLOOD, 2001, 98 (07) :2143-2151